Yifan K. Liu

393 Middle Huaxia Road
Shanghai, 201210, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 184 publications

Author Correction: Engineered living glues secrete therapeutic proteins for treatment of inflammatory bowel disease.

Author Correction: Engineered living glues secrete therapeutic proteins for treatment of inflammatory bowel disease.

Journal: Nature biotechnology
Published: August 11, 2026

AI-integrated single-cell multi-omics decodes the hepatocellular carcinoma metabolism-immune axis: a new strategy for precision therapeutic targeting.

AI-integrated single-cell multi-omics decodes the hepatocellular carcinoma metabolism-immune axis: a new strategy for precision therapeutic targeting.

Journal: Frontiers in oncology
Published: June 21, 2026

Research on N-doped modified Weigela japonica-based porous carbon and its zinc ion hybrid capacitors energy storage.

Research on N-doped modified Weigela japonica-based porous carbon and its zinc ion hybrid capacitors energy storage.

Journal: iScience
Published: June 12, 2026

Measurement-Efficient Few-Shot Vibration Fault Diagnosis via Physics-Informed Self-Supervised Learning and Adaptive Early Stopping.

Measurement-Efficient Few-Shot Vibration Fault Diagnosis via Physics-Informed Self-Supervised Learning and Adaptive Early Stopping.

Journal: Sensors (Basel, Switzerland)
Published: May 18, 2026

Predicting CAR-T outcomes in R/R DLBCL: a multicenter real-world study of a 5-index model.

Predicting CAR-T outcomes in R/R DLBCL: a multicenter real-world study of a 5-index model.

Journal: Frontiers in immunology
Published: April 23, 2026

Re: Fecal Microbiota Transplantation plus Immunotherapy in Metastatic Renal Cell Carcinoma: The Phase 1 PERFORM Trial.

Re: Fecal Microbiota Transplantation plus Immunotherapy in Metastatic Renal Cell Carcinoma: The Phase 1 PERFORM Trial.

Journal: European urology
Published: April 10, 2026

Correction: Novel non-viral in vivo CAR-T therapies: latest updates from the 2025 ASH annual meeting.

Correction: Novel non-viral in vivo CAR-T therapies: latest updates from the 2025 ASH annual meeting.

Journal: Experimental hematology & oncology
Published: April 06, 2026

ZIF-8 nanoplatform coordinating Zn2+ overload and STING activation for enhanced prostate cancer immunotherapy.

ZIF-8 nanoplatform coordinating Zn2+ overload and STING activation for enhanced prostate cancer immunotherapy.

Journal: International journal of pharmaceutics: X
Published: March 20, 2026

Iron Borate Nanobeams for Magnetic Resonance Imaging-Guided Boron Neutron Capture Therapy.

Iron Borate Nanobeams for Magnetic Resonance Imaging-Guided Boron Neutron Capture Therapy.

Journal: ACS nano
Published: March 16, 2026

Re: Fecal Microbiota Transplantation plus Pembrolizumab and Axitinib in Metastatic Renal Cell Carcinoma: The Randomized Phase 2 TACITO Trial.

Re: Fecal Microbiota Transplantation plus Pembrolizumab and Axitinib in Metastatic Renal Cell Carcinoma: The Randomized Phase 2 TACITO Trial.

Journal: European urology
Published: March 11, 2026

Early admission to hospital with lack of prehospital treatments is an adverse prognostic factor for severely burned patients: A case-control study.

Early admission to hospital with lack of prehospital treatments is an adverse prognostic factor for severely burned patients: A case-control study.

Journal: Current problems in surgery
Published: February 11, 2026

Re: HIF-2-dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear Cell Renal Cell Carcinoma.

Re: HIF-2-dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear Cell Renal Cell Carcinoma.

Journal: European urology
Published: February 08, 2026
Showing 1-12 of 184

Last Updated: 09/26/2026